Product image of Xolair (Omalizumab) supplied by GNH India

Xolair

Active Ingredient:
Omalizumab
Origin:
EU

Xolair (Omalizumab)

Xolair (omalizumab) is a prescription biologic used to help manage allergic asthma and chronic hives. It works by targeting immunoglobulin E to reduce allergic reactions. This injectable therapy is designed for long-term symptom control. Seek medical guidance before use.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xolair is used to treat moderate to severe persistent allergic asthma in patients who have a positive skin test or blood test for allergens. It is also approved for chronic idiopathic urticaria, a condition causing persistent hives without a known cause. Patients often ask, what is Xolair used for, and it helps reduce the frequency of asthma attacks and hives flare-ups.

Side Effects

  • Many patients report fewer allergy symptoms and improved breathing after starting Xolair therapy. Some experience a reduction in skin reactions like itching and swelling associated with chronic hives. Effects may take several weeks to become noticeable as the medication works gradually.

Precautions & Warnings

  • Xolair should be administered by a healthcare professional in a clinical setting. Patients with a history of severe allergic reactions should use caution. Keep emergency medical contact information readily available during treatment. Always inform your provider about current medications and health conditions before starting Xolair.

Avoid Interactions

  • Xolair may interact with other biologics or immunosuppressants, potentially increasing infection risk. No specific drug interactions are widely documented, but caution is advised when combining with other therapies affecting the immune system. Alcohol and certain foods do not typically interact with Xolair, but discuss all substances with your healthcare provider.

Frequently Asked Questions

Xolair is used to treat moderate to severe allergic asthma and chronic hives in patients who do not respond adequately to other treatments.

Xolair is given as an injection under the skin (subcutaneous) by a healthcare professional, typically every 2 to 4 weeks.

Xolair is not approved for treating food allergies, though research is ongoing for potential future uses.

Common side effects may include injection site reactions, headache, and fatigue. Severe allergic reactions are rare but possible.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Omalizumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT